Ormat Technologies, Inc. (ORA) Analysts See $0.55 EPS; Walleye Trading Has Decreased By $581,400 Its Teva Pharmaceutical Inds LTD (Call) (TEVA) Stake

January 24, 2018 - By Marie Mckinney

Walleye Trading Llc decreased Teva Pharmaceutical Inds Ltd (Call) (TEVA) stake by 11.23% reported in 2017Q3 SEC filing. Walleye Trading Llc sold 34,200 shares as Teva Pharmaceutical Inds Ltd (Call) (TEVA)’s stock declined 15.11%. The Walleye Trading Llc holds 270,300 shares with $4.76M value, down from 304,500 last quarter. Teva Pharmaceutical Inds Ltd (Call) now has $20.91B valuation. The stock decreased 1.79% or $0.374 during the last trading session, reaching $20.576. About 9.45 million shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 24, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Analysts expect Ormat Technologies, Inc. (NYSE:ORA) to report $0.55 EPS on February, 27.They anticipate $0.01 EPS change or 1.79% from last quarter’s $0.56 EPS. ORA’s profit would be $27.83 million giving it 30.33 P/E if the $0.55 EPS is correct. After having $0.42 EPS previously, Ormat Technologies, Inc.’s analysts see 30.95% EPS growth. The stock increased 0.53% or $0.35 during the last trading session, reaching $66.72. About 93,149 shares traded. Ormat Technologies, Inc. (NYSE:ORA) has risen 34.71% since January 24, 2017 and is uptrending. It has outperformed by 18.01% the S&P500.

Ormat Technologies, Inc. engages in geothermal and recovered energy power business worldwide. The company has market cap of $3.38 billion. The firm operates in two divisions, Electricity and Product. It has a 28.64 P/E ratio. The Electricity segment develops, builds, owns, and operates geothermal and recovered energy power plants; and sells electricity.

Among 8 analysts covering Ormat Technologies Inc (NYSE:ORA), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Ormat Technologies Inc had 17 analyst reports since January 4, 2016 according to SRatingsIntel. The stock of Ormat Technologies, Inc. (NYSE:ORA) earned “Equal-Weight” rating by Barclays Capital on Friday, May 26. J.P. Morgan upgraded it to “Buy” rating and $7100 target in Wednesday, June 7 report. The stock of Ormat Technologies, Inc. (NYSE:ORA) earned “Buy” rating by Cowen & Co on Friday, August 18. Cowen & Co maintained the shares of ORA in report on Monday, October 23 with “Buy” rating. The firm has “Mkt Outperform” rating by Avondale given on Monday, December 19. On Wednesday, June 7 the stock rating was upgraded by JP Morgan to “Overweight”. As per Friday, May 6, the company rating was downgraded by JP Morgan. The firm has “Buy” rating by Cowen & Co given on Monday, July 17. The firm earned “Buy” rating on Monday, November 13 by Roth Capital. The stock has “Buy” rating by Oppenheimer on Thursday, June 1.

Investors sentiment decreased to 1.1 in Q3 2017. Its down 0.20, from 1.3 in 2017Q2. It worsened, as 16 investors sold Ormat Technologies, Inc. shares while 52 reduced holdings. 18 funds opened positions while 57 raised stakes. 20.98 million shares or 1.96% more from 20.58 million shares in 2017Q2 were reported. Asset Mngmt One owns 4,309 shares. Miller Howard Investments owns 29,219 shares for 0.04% of their portfolio. Malaga Cove Ltd Liability Corporation owns 27,110 shares for 0.95% of their portfolio. 4,665 were reported by Great West Life Assurance Comm Can. Bluestein R H & Co holds 8,000 shares. Gamco Et Al invested in 0.03% or 86,000 shares. Howe Rusling reported 40 shares or 0% of all its holdings. Renaissance Ltd reported 1.27 million shares. Fmr Limited Liability Co owns 0% invested in Ormat Technologies, Inc. (NYSE:ORA) for 154,178 shares. Amp Investors Ltd has 6,000 shares for 0% of their portfolio. Deutsche Fincl Bank Ag reported 0.01% in Ormat Technologies, Inc. (NYSE:ORA). Boston Limited holds 77,047 shares. Citigroup accumulated 11,209 shares. Mcf Limited Co reported 200 shares. Natixis holds 4,961 shares.

Since August 7, 2017, it had 0 buys, and 11 insider sales for $7.29 million activity. Argas Shlomi had sold 11,523 shares worth $685,619 on Wednesday, September 27. Klein Erez also sold $1.45 million worth of Ormat Technologies, Inc. (NYSE:ORA) shares. Granot David also sold $144,150 worth of Ormat Technologies, Inc. (NYSE:ORA) shares. Hatzir Shimon sold $285,737 worth of Ormat Technologies, Inc. (NYSE:ORA) on Tuesday, September 19. Shares for $467,091 were sold by Krieger Zvi. 9,983 shares were sold by Rosner Etty, worth $601,276. $433,125 worth of stock was sold by JOYAL ROBERT EUGENE on Monday, August 7.

Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on February, 12. They expect $0.75 earnings per share, down 44.85% or $0.61 from last year’s $1.36 per share. TEVA’s profit will be $761.99 million for 6.86 P/E if the $0.75 EPS becomes a reality. After $0.95 actual earnings per share reported by Teva Pharmaceutical Industries Limited for the previous quarter, Wall Street now forecasts -21.05% negative EPS growth.